Long-term outcome of magnetic resonance spectroscopic image–directed dose escalation for prostate brachytherapy

Ítems similars

• Dose to the Bladder Neck Is the Most Important Predictor for Acute and Late Toxicity After Low-Dose-Rate Prostate Brachytherapy: Implications for Establishing New Dose Constraints for Treatment Planning
  per: Hathout, Lara, et al.
  Publicat: (2014)
• Placement of an Absorbable Rectal Hydrogel Spacer in Patients Undergoing Low-dose-rate Brachytherapy with Palladium-103
  per: Taggar, Amandeep S, et al.
  Publicat: (2017)
• A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy
  per: Yamada, Yoshiya, et al.
  Publicat: (2013)
• Comparison of Tumor Control and Toxicity Outcomes of High Dose Intensity-Modulated Radiotherapy and Brachytherapy for Patients with Favorable Risk Prostate Cancer
  per: Zelefsky, Michael J., et al.
  Publicat: (2010)
• Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy
  per: Nasser, Nicola J., et al.
  Publicat: (2016)